alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › p-tau181

p-tau181

7 studies tagged p-tau181, dated 2022-06-08 to 2025-03-06. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients 2025-03-06
  2. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases 2024-03-27
  3. Influence of Physiological Variables and Comorbidities on Plasma Aβ40, Aβ42, and p-tau181 Levels in Cognitively Unimpaired Individuals 2024-01-25

Studies

7 studies carry this tag.

Date range

2022 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Acta neuropathologica communications 1
  • Alzheimer's research & therapy 1
  • International journal of molecular sciences 1
  • Parkinsonism & related disorders 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Scientific reports 2025-03-06 Biomarkers

    We investigated plasma phosphorylated tau217 (p-tau217) and p-tau181 efficacy in predicting positive amyloid positron emission tomography (PET) results and cognitive stage transitions.

  2. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Acta neuropathologica communications 2024-03-27 Biomarkers

    Recent studies suggest that increased cerebrospinal fluid (CSF) phospho-tau is associated with brain amyloid pathology rather than the tau pathology.

  3. Influence of Physiological Variables and Comorbidities on Plasma Aβ40, Aβ42, and p-tau181 Levels in Cognitively Unimpaired Individuals

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. International journal of molecular sciences 2024-01-25 Biomarkers

    Plasma biomarkers for Alzheimer's disease (AD) are a promising tool that may help in early diagnosis.

  4. Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-10-19 Biomarkers

    Plasma BD-tau and p-tau181 mimic their corresponding cerebrospinal fluid (CSF) markers.

  5. Predicting cognitive stage transition using p-tau181, Centiloid, and other measures

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-03-29 Biomarkers

    Plasma p-tau181 and Centiloid scale alone or in combination with other biomarkers, might predict future cognitive stage transition in non-dementia patients.

  6. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's research & therapy 2022-12-22 Biomarkers

    CSF tau368 concentration was not significantly different across the diagnostic groups, although a modest increase was observed in all groups as compared with healthy young individuals (all P < 0.01).

  7. Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Parkinsonism & related disorders 2022-06-08 Biomarkers

    Plasma NfL levels objectively differentiates PD-MCI from PD-NC patients, and may serve as a plasma biomarker for predicting progression to dementia in PD.

All topic tags with their study counts